ID: ALA4442619

Max Phase: Preclinical

Molecular Formula: C18H26N2O3

Molecular Weight: 318.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCN1CCc2ccc(OCCCN3CCOCC3)cc2C1=O

Standard InChI:  InChI=1S/C18H26N2O3/c1-2-20-8-6-15-4-5-16(14-17(15)18(20)21)23-11-3-7-19-9-12-22-13-10-19/h4-5,14H,2-3,6-13H2,1H3

Standard InChI Key:  MLGRKAGRTKIEEG-UHFFFAOYSA-N

Associated Targets(non-human)

Histamine H1 receptor 2054 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.42Molecular Weight (Monoisotopic): 318.1943AlogP: 1.81#Rotatable Bonds: 6
Polar Surface Area: 42.01Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.98CX LogP: 1.37CX LogD: 1.23
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -1.15

References

1. Dou F, Cao X, Jing P, Wu C, Zhang Y, Chen Y, Zhang G..  (2019)  Synthesis and evaluation of histamine H3 receptor ligand based on lactam scaffold as agents for treating neuropathic pain.,  29  (12): [PMID:30981577] [10.1016/j.bmcl.2019.04.015]

Source